首页 > 最新文献

European Journal of Oncology Nursing最新文献

英文 中文
Profiles of chemotherapy-induced peripheral neuropathy in breast cancer patients undergoing taxane-based chemotherapy: A latent class analysis. 接受紫杉烷类化疗的乳腺癌患者化疗诱导的周围神经病变概况:一项潜在分类分析。
IF 2.7 3区 医学 Q1 NURSING Pub Date : 2024-12-07 DOI: 10.1016/j.ejon.2024.102758
Ruo-Lin Li, Li-Xiao Bai, Yu Liu, Ai-Ling Yang, Lu Chen, Fu-Yun Zhao, Ling Zhang, Jun-E Liu

Purpose: This study aimed to identify the potential subgroups of chemotherapy-induced peripheral neuropathy (CIPN) in breast cancer patients undergoing taxane-based chemotherapy and examine the association of the latent subtype with patient characteristics.

Methods: This multi-center, cross-sectional investigation was conducted between April 2022 and March 2023. CIPN was evaluated using the Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity scale. Latent class analysis was employed to identify distinct CIPN subgroups, and multinomial logistic regression was used to analyze the associations between these subgroups and patient characteristics.

Results: In total, 397 individuals were categorized into three subgroups: high symptoms with high dysfunction (Class 1; 25.4%), moderate symptoms with low dysfunction (Class 2; 39.2%), and low symptoms with low dysfunction (Class 3; 35.3%). Taxane type, chemotherapy cycles, fatigue, β-blocker use, and depression were significant predictors of the subgroups (P < .05).

Conclusion: CIPN symptoms in breast cancer patients are heterogeneous. Significant factors for the latent subgroups included taxane type, chemotherapy cycles, β-blocker use, fatigue, and depression. Identifying different subgroups of chemotherapy-induced peripheral neuropathy would help develop interventions tailored to the patients.

目的:本研究旨在确定接受紫杉烷类化疗的乳腺癌患者化疗诱导的周围神经病变(CIPN)的潜在亚群,并研究潜在亚型与患者特征的关系。方法:于2022年4月至2023年3月进行多中心横断面调查。CIPN采用肿瘤治疗功能评估/妇科肿瘤组神经毒性量表进行评估。使用潜类分析来识别不同的CIPN亚组,并使用多项逻辑回归来分析这些亚组与患者特征之间的关系。结果:共有397人被分为三个亚组:高症状和高功能障碍(1类;25.4%),中度症状伴低功能障碍(2类;39.2%),低症状伴低功能障碍(3类;35.3%)。紫杉烷类型、化疗周期、疲劳、β受体阻滞剂使用和抑郁是亚组的显著预测因子(P结论:乳腺癌患者的CIPN症状具有异质性。潜在亚组的重要因素包括紫杉烷类型、化疗周期、β受体阻滞剂的使用、疲劳和抑郁。确定化疗引起的周围神经病变的不同亚组将有助于制定针对患者的干预措施。
{"title":"Profiles of chemotherapy-induced peripheral neuropathy in breast cancer patients undergoing taxane-based chemotherapy: A latent class analysis.","authors":"Ruo-Lin Li, Li-Xiao Bai, Yu Liu, Ai-Ling Yang, Lu Chen, Fu-Yun Zhao, Ling Zhang, Jun-E Liu","doi":"10.1016/j.ejon.2024.102758","DOIUrl":"https://doi.org/10.1016/j.ejon.2024.102758","url":null,"abstract":"<p><strong>Purpose: </strong>This study aimed to identify the potential subgroups of chemotherapy-induced peripheral neuropathy (CIPN) in breast cancer patients undergoing taxane-based chemotherapy and examine the association of the latent subtype with patient characteristics.</p><p><strong>Methods: </strong>This multi-center, cross-sectional investigation was conducted between April 2022 and March 2023. CIPN was evaluated using the Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity scale. Latent class analysis was employed to identify distinct CIPN subgroups, and multinomial logistic regression was used to analyze the associations between these subgroups and patient characteristics.</p><p><strong>Results: </strong>In total, 397 individuals were categorized into three subgroups: high symptoms with high dysfunction (Class 1; 25.4%), moderate symptoms with low dysfunction (Class 2; 39.2%), and low symptoms with low dysfunction (Class 3; 35.3%). Taxane type, chemotherapy cycles, fatigue, β-blocker use, and depression were significant predictors of the subgroups (P < .05).</p><p><strong>Conclusion: </strong>CIPN symptoms in breast cancer patients are heterogeneous. Significant factors for the latent subgroups included taxane type, chemotherapy cycles, β-blocker use, fatigue, and depression. Identifying different subgroups of chemotherapy-induced peripheral neuropathy would help develop interventions tailored to the patients.</p>","PeriodicalId":51048,"journal":{"name":"European Journal of Oncology Nursing","volume":"74 ","pages":"102758"},"PeriodicalIF":2.7,"publicationDate":"2024-12-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142822953","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A cross-sectional analysis to characterise treatment decision making for advanced cancer at a tertiary treatment centre: Where can we improve the process? 三级治疗中心晚期癌症治疗决策特征的横断面分析:我们在哪里可以改进这一过程?
IF 2.7 3区 医学 Q1 NURSING Pub Date : 2024-12-07 DOI: 10.1016/j.ejon.2024.102762
Grant Punnett, Melissa Perry, Charlotte Eastwood, Laura Green, Florian Walter, Janelle Yorke

Purpose: In decisions relating to cancer treatment, the risks and benefits of treatment and the patient's preferences must be considered to ensure concordance with goals of care. Shared decision making (SDM) can facilitate these discussions and is associated with reduced decision conflict. This study aimed to characterise decision making for advanced cancer patients at a UK tertiary cancer centre and identify who may be at risk of suboptimal SDM and increased decision conflict.

Methods: Participants completed the SDM-Q-9, decision conflict and decision self-efficacy scale following a consultation where an advanced cancer treatment decision was made. Pearson's chi-square test identified patient characteristics associated with SDM-Q-9, decision self-efficacy and decision conflict score categories; odds ratios were calculated to determine which patients were at increased probability of experiencing suboptimal SDM, low decision self-efficacy or high decision conflict.

Results: Participant's (n = 211) scores indicated predominantly high SDM, high decision self-efficacy and low decision conflict. Patient gender and the presence of an informal caregiver in consultation were significantly associated with SDM-Q-9 score category (p > 0.05). Female patients (OR = 2.466, 95% CI: 1.223-4.974) and those attending consultations alone (OR = 0.440, 95% CI: 0.222-0.874) had greater odds of reporting lower SDM scores.

Conclusion: High SDM scores indicate either effective SDM behaviours or satisfaction with care biasing responses. Greater support to engage with SDM is required for female patients and those who attend alone in advanced cancer treatment decision consultations.

目的:在与癌症治疗有关的决策中,必须考虑治疗的风险和益处以及患者的偏好,以确保与护理目标一致。共享决策制定(SDM)可以促进这些讨论,并与减少决策冲突有关。本研究旨在描述英国三级癌症中心晚期癌症患者的决策特征,并确定哪些患者可能面临次优SDM风险和决策冲突增加的风险。方法:参与者在会诊后完成SDM-Q-9、决策冲突和决策自我效能量表,并做出晚期癌症治疗决策。皮尔逊卡方检验确定了与SDM-Q-9、决策自我效能和决策冲突评分类别相关的患者特征;计算比值比以确定哪些患者经历次优SDM、低决策自我效能或高决策冲突的可能性增加。结果:被试(n = 211)得分以高SDM、高决策自我效能和低决策冲突为主。患者性别和就诊时是否有非正式照护者与SDM-Q-9评分类别显著相关(p < 0.05)。女性患者(OR = 2.466, 95% CI: 1.223-4.974)和单独参加会诊的患者(OR = 0.440, 95% CI: 0.222-0.874)报告SDM评分较低的几率更大。结论:高SDM分数表明有效的SDM行为或对护理偏向反应的满意度。女性患者和那些单独参加晚期癌症治疗决策咨询的患者需要更多的支持参与SDM。
{"title":"A cross-sectional analysis to characterise treatment decision making for advanced cancer at a tertiary treatment centre: Where can we improve the process?","authors":"Grant Punnett, Melissa Perry, Charlotte Eastwood, Laura Green, Florian Walter, Janelle Yorke","doi":"10.1016/j.ejon.2024.102762","DOIUrl":"https://doi.org/10.1016/j.ejon.2024.102762","url":null,"abstract":"<p><strong>Purpose: </strong>In decisions relating to cancer treatment, the risks and benefits of treatment and the patient's preferences must be considered to ensure concordance with goals of care. Shared decision making (SDM) can facilitate these discussions and is associated with reduced decision conflict. This study aimed to characterise decision making for advanced cancer patients at a UK tertiary cancer centre and identify who may be at risk of suboptimal SDM and increased decision conflict.</p><p><strong>Methods: </strong>Participants completed the SDM-Q-9, decision conflict and decision self-efficacy scale following a consultation where an advanced cancer treatment decision was made. Pearson's chi-square test identified patient characteristics associated with SDM-Q-9, decision self-efficacy and decision conflict score categories; odds ratios were calculated to determine which patients were at increased probability of experiencing suboptimal SDM, low decision self-efficacy or high decision conflict.</p><p><strong>Results: </strong>Participant's (n = 211) scores indicated predominantly high SDM, high decision self-efficacy and low decision conflict. Patient gender and the presence of an informal caregiver in consultation were significantly associated with SDM-Q-9 score category (p > 0.05). Female patients (OR = 2.466, 95% CI: 1.223-4.974) and those attending consultations alone (OR = 0.440, 95% CI: 0.222-0.874) had greater odds of reporting lower SDM scores.</p><p><strong>Conclusion: </strong>High SDM scores indicate either effective SDM behaviours or satisfaction with care biasing responses. Greater support to engage with SDM is required for female patients and those who attend alone in advanced cancer treatment decision consultations.</p>","PeriodicalId":51048,"journal":{"name":"European Journal of Oncology Nursing","volume":"74 ","pages":"102762"},"PeriodicalIF":2.7,"publicationDate":"2024-12-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142973129","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The effects of a psychoeducational intervention on caregivers of colorectal cancer patients: A meta-analysis of randomized controlled trials. 心理教育干预对大肠癌患者护理人员的影响:随机对照试验的荟萃分析。
IF 2.7 3区 医学 Q1 NURSING Pub Date : 2024-11-28 DOI: 10.1016/j.ejon.2024.102739
Menghan Zhang, Yanyan Xue, Mengwei Shao, Yi Yang, Lulu Yu, Bin Ma, Dunhui Li, Huiyue Zhou, Kun Wang, Changying Chen, Mengzhuo Cheng, Tao Wang

Purpose: To investigate the impacts of psychoeducational interventions in adjusting the physical and psychological statuses of caregivers of CRC patients.

Methods: Nine electronic databases, including Medline, Web of Science, Embase, Cochrane Library, CINAHL Complete, CNKI, Wan Fang Database, VIP Database, and CBM, were searched to identify eligible randomized controlled trials from January 2000 to July 2023. From 1498 articles, 9 articles that met the inclusion criteria were identified and systematically analyzed. Effect sizes and moderator variables were tested using both fixed-effect models and random-effect models.

Results: Our results clearly showed that although psychoeducational interventions could improve all aspects of the physical health of caregivers of CRC patients, resulting in improved quality of life, reduced caregiver burden, and enhanced caregiver ability, they only partly affect the psychological conditions of caregivers. For example, while it led to improved positive coping, alleviated negative coping, and decreased disruption in the caring schedule, there were quite a few key aspects of the psychological status that did not show responses, including perception of family support, financial burden, self-esteem, and distress.

Conclusion: Psychoeducational interventions can significantly improve the status of caregivers of CRC both physically and psychologically and encourage active lifestyles. However, there are still outstanding problems to be solved in the psychological aspects of caregivers, such as how to improve their social support, and how to relieve their financial pressure. Even so, we firmly believe developing a standardized psychoeducational intervention mode is of great significance in improving the general well-being of caregivers of CRC patients.

Systematic review registration: PROSPERO (http://www.crd.york.ac.uk/PROSPERO), number CRD42023484775.

目的:探讨心理教育干预对调节结直肠癌患者照护者身心状态的影响。方法:检索Medline、Web of Science、Embase、Cochrane Library、CINAHL Complete、CNKI、万方数据库、VIP数据库、CBM等9个电子数据库,筛选2000年1月至2023年7月的随机对照试验。从1498篇文献中筛选出9篇符合纳入标准的文献进行系统分析。采用固定效应模型和随机效应模型对效应大小和调节变量进行检验。结果:我们的研究结果清楚地表明,虽然心理教育干预可以改善CRC患者照顾者各方面的身体健康,从而改善生活质量,减轻照顾者负担,增强照顾者能力,但仅部分影响照顾者的心理状况。例如,虽然它改善了积极应对,减轻了消极应对,减少了照顾计划的中断,但心理状态的许多关键方面没有表现出反应,包括对家庭支持的感知,经济负担,自尊和痛苦。结论:心理教育干预能显著改善结直肠癌照护者的生理和心理状况,鼓励积极的生活方式。然而,在照顾者的心理方面仍有突出的问题需要解决,如如何提高他们的社会支持,如何缓解他们的经济压力。尽管如此,我们坚信,制定标准化的心理教育干预模式对于提高CRC患者照护者的整体幸福感具有重要意义。系统评价注册:PROSPERO (http://www.crd.york.ac.uk/PROSPERO),编号CRD42023484775。
{"title":"The effects of a psychoeducational intervention on caregivers of colorectal cancer patients: A meta-analysis of randomized controlled trials.","authors":"Menghan Zhang, Yanyan Xue, Mengwei Shao, Yi Yang, Lulu Yu, Bin Ma, Dunhui Li, Huiyue Zhou, Kun Wang, Changying Chen, Mengzhuo Cheng, Tao Wang","doi":"10.1016/j.ejon.2024.102739","DOIUrl":"https://doi.org/10.1016/j.ejon.2024.102739","url":null,"abstract":"<p><strong>Purpose: </strong>To investigate the impacts of psychoeducational interventions in adjusting the physical and psychological statuses of caregivers of CRC patients.</p><p><strong>Methods: </strong>Nine electronic databases, including Medline, Web of Science, Embase, Cochrane Library, CINAHL Complete, CNKI, Wan Fang Database, VIP Database, and CBM, were searched to identify eligible randomized controlled trials from January 2000 to July 2023. From 1498 articles, 9 articles that met the inclusion criteria were identified and systematically analyzed. Effect sizes and moderator variables were tested using both fixed-effect models and random-effect models.</p><p><strong>Results: </strong>Our results clearly showed that although psychoeducational interventions could improve all aspects of the physical health of caregivers of CRC patients, resulting in improved quality of life, reduced caregiver burden, and enhanced caregiver ability, they only partly affect the psychological conditions of caregivers. For example, while it led to improved positive coping, alleviated negative coping, and decreased disruption in the caring schedule, there were quite a few key aspects of the psychological status that did not show responses, including perception of family support, financial burden, self-esteem, and distress.</p><p><strong>Conclusion: </strong>Psychoeducational interventions can significantly improve the status of caregivers of CRC both physically and psychologically and encourage active lifestyles. However, there are still outstanding problems to be solved in the psychological aspects of caregivers, such as how to improve their social support, and how to relieve their financial pressure. Even so, we firmly believe developing a standardized psychoeducational intervention mode is of great significance in improving the general well-being of caregivers of CRC patients.</p><p><strong>Systematic review registration: </strong>PROSPERO (http://www.crd.york.ac.uk/PROSPERO), number CRD42023484775.</p>","PeriodicalId":51048,"journal":{"name":"European Journal of Oncology Nursing","volume":"74 ","pages":"102739"},"PeriodicalIF":2.7,"publicationDate":"2024-11-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142899731","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Influence of oncology nurses' decision-making and personality traits on missed nursing care and related factors: A correlational study. 肿瘤科护士决策及人格特质对护理失察的影响及相关因素的相关研究。
IF 2.7 3区 医学 Q1 NURSING Pub Date : 2024-11-27 DOI: 10.1016/j.ejon.2024.102749
Ivo C S Paiva, Filipa I Q S Ventura, António C L Vilela, Isabel M P B Moreira

Purpose: To identify Missed Nursing Care (MNC) and related factors, as well as analyze the influence of nurses' decision-making and personality traits on MNC in two Portuguese hospitals dedicated to cancer care.

Methods: A cross-sectional, multicentric, descriptive-correlational study was conducted using a convenience sample of 298 nurses working in two hospitals dedicated to cancer care. Data were collected in the first semester of 2023 using a questionnaire that included sociodemographic and professional questions and the Portuguese versions of the MISSCARE Survey, the Nursing Decision-Making Instrument (NDMI-PT), and the Ten-Item Personality Inventory (TIPI-P).

Results: Nurses missed care occasionally, namely in the dimensions related to Patient empowerment/autonomy care and Efficacy of feeding and medication. Staffing, Patient volume and acuity, and Management and organization were moderate to significant reasons for MNC. The flexible decision-making style was predominant (81.5%). The most prevalent personality traits were Conscientiousness, Agreeableness, and Openness to experience. Significant correlations were found between the four stages of the decision-making process and the personality traits and several dimensions of MNC. Data collection to assess a patient's condition was negatively correlated with Team communication and Material resources. Similarly, the Emotional stability trait was negatively correlated with Team communication and Patient volume and acuity.

Conclusions: This study identified MNC and factors that can influence the quality of care. It is crucial to promote nurses' training and specialization within healthcare teams, with a particular focus on enhancing some of their personality traits to make them more effective and efficient therapeutic agents.

目的:了解葡萄牙两家癌症医院护士护理缺失(MNC)及相关因素,分析护士决策和人格特质对MNC的影响。方法:采用横断面、多中心、描述性相关研究,选取两家癌症护理医院的298名护士作为方便样本。数据收集于2023年第一学期,使用问卷调查,包括社会人口统计学和专业问题,葡萄牙语版MISSCARE调查,护理决策工具(NDMI-PT)和十项人格量表(TIPI-P)。结果:护士在患者授权/自主护理和喂养用药效果相关维度中偶尔出现护理缺失。人员配备、患者数量和敏锐度、管理和组织是导致跨国公司发生的中等到重要原因。灵活决策方式占主导地位(81.5%)。最普遍的性格特征是尽责性、宜人性和开放性。决策过程的四个阶段与跨国公司的人格特质和几个维度之间存在显著的相关性。评估患者病情的数据收集与团队沟通和物质资源呈负相关。同样,情绪稳定特质与团队沟通、患者数量和敏锐度呈负相关。结论:本研究确定了MNC和影响护理质量的因素。在医疗团队中促进护士的培训和专业化是至关重要的,特别注重提高他们的一些个性特征,使他们成为更有效和高效的治疗药物。
{"title":"Influence of oncology nurses' decision-making and personality traits on missed nursing care and related factors: A correlational study.","authors":"Ivo C S Paiva, Filipa I Q S Ventura, António C L Vilela, Isabel M P B Moreira","doi":"10.1016/j.ejon.2024.102749","DOIUrl":"https://doi.org/10.1016/j.ejon.2024.102749","url":null,"abstract":"<p><strong>Purpose: </strong>To identify Missed Nursing Care (MNC) and related factors, as well as analyze the influence of nurses' decision-making and personality traits on MNC in two Portuguese hospitals dedicated to cancer care.</p><p><strong>Methods: </strong>A cross-sectional, multicentric, descriptive-correlational study was conducted using a convenience sample of 298 nurses working in two hospitals dedicated to cancer care. Data were collected in the first semester of 2023 using a questionnaire that included sociodemographic and professional questions and the Portuguese versions of the MISSCARE Survey, the Nursing Decision-Making Instrument (NDMI-PT), and the Ten-Item Personality Inventory (TIPI-P).</p><p><strong>Results: </strong>Nurses missed care occasionally, namely in the dimensions related to Patient empowerment/autonomy care and Efficacy of feeding and medication. Staffing, Patient volume and acuity, and Management and organization were moderate to significant reasons for MNC. The flexible decision-making style was predominant (81.5%). The most prevalent personality traits were Conscientiousness, Agreeableness, and Openness to experience. Significant correlations were found between the four stages of the decision-making process and the personality traits and several dimensions of MNC. Data collection to assess a patient's condition was negatively correlated with Team communication and Material resources. Similarly, the Emotional stability trait was negatively correlated with Team communication and Patient volume and acuity.</p><p><strong>Conclusions: </strong>This study identified MNC and factors that can influence the quality of care. It is crucial to promote nurses' training and specialization within healthcare teams, with a particular focus on enhancing some of their personality traits to make them more effective and efficient therapeutic agents.</p>","PeriodicalId":51048,"journal":{"name":"European Journal of Oncology Nursing","volume":"74 ","pages":"102749"},"PeriodicalIF":2.7,"publicationDate":"2024-11-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142808478","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Development of a supportive cancer care model for patients with CAncer and pre-existing SEvere MEntal Disorders. 对癌症患者和先前存在的严重精神障碍患者的支持性癌症护理模式的发展。
IF 2.7 3区 医学 Q1 NURSING Pub Date : 2024-11-22 DOI: 10.1016/j.ejon.2024.102748
Louise Elkjær Fløe, Josefine Maria Bruun, Jesper Grau Eriksen, Poul Videbech, Mette Asbjørn Neergaard, Anna Mygind

Purpose: Cancer patients with pre-existing severe mental disorders (SMD), including moderate to severe depression, bipolar disorder and schizophrenia, have reduced life expectancy and are less likely to receive optimal cancer treatment. The aim of this study is to develop and pilot test a supportive care model, to enhance cancer care in this population.

Methods: The model was developed through three phases. In phase I, a barrier analysis and prototype of the model were conducted from reviewing the literature and through 162 informal interviews with healthcare professionals, patients and patient representatives. In phase II, the prototype was refined through four workshops with a total of five cancer nurses, four clinical oncologists, three psychiatrists, two general practitioners, one psychologist, and 16 patient representatives. Thereafter, a pilot test with 13 patients was carried out, where continuous adaptations to the prototype from phase II, were made. The quantitative and qualitative data were analysed focusing on components which were prominent and able to fit into the clinical setting.

Results: The final CASEMED supportive cancer care model included: Early identification of psychiatric comorbidity, engagement of significant caregivers, education of the oncological HCPs, securing continuity among staff and enhanced collaboration between sectors. The latter was achieved through an online psychiatric multidisciplinary team conference where the patient's general practitioner, a psychiatrist and the patient's oncologist participated.

Conclusion: This study indicates that the model can be implemented in practice and has the potential to optimize cancer care for patients with cancer and pre-existing SMD. A larger feasibility study is currently being conducted.

目的:患有严重精神障碍(SMD)的癌症患者,包括中度至重度抑郁症、双相情感障碍和精神分裂症,预期寿命缩短,接受最佳癌症治疗的可能性较小。本研究的目的是开发和试点测试一种支持性护理模式,以提高这一人群的癌症护理。方法:分三个阶段建立模型。在第一阶段,通过回顾文献,并通过对医疗保健专业人员、患者和患者代表的162次非正式访谈,进行了障碍分析和模型原型。在第二阶段,原型通过四个研讨会进行完善,共有五名癌症护士、四名临床肿瘤学家、三名精神科医生、两名全科医生、一名心理学家和16名患者代表。此后,对13名患者进行了试点测试,并对第二阶段的原型进行了持续调整。对定量和定性数据进行分析,重点关注那些突出且能够适应临床环境的成分。结果:最终的CASEMED支持性癌症治疗模式包括:精神疾病合并症的早期识别,重要护理人员的参与,肿瘤HCPs的教育,确保员工之间的连续性和加强部门之间的合作。后者是通过在线精神病学多学科团队会议实现的,患者的全科医生、精神科医生和患者的肿瘤学家参加了会议。结论:本研究表明,该模型可以在实践中实施,并具有优化癌症和既往SMD患者癌症护理的潜力。目前正在进行一项更大规模的可行性研究。
{"title":"Development of a supportive cancer care model for patients with CAncer and pre-existing SEvere MEntal Disorders.","authors":"Louise Elkjær Fløe, Josefine Maria Bruun, Jesper Grau Eriksen, Poul Videbech, Mette Asbjørn Neergaard, Anna Mygind","doi":"10.1016/j.ejon.2024.102748","DOIUrl":"https://doi.org/10.1016/j.ejon.2024.102748","url":null,"abstract":"<p><strong>Purpose: </strong>Cancer patients with pre-existing severe mental disorders (SMD), including moderate to severe depression, bipolar disorder and schizophrenia, have reduced life expectancy and are less likely to receive optimal cancer treatment. The aim of this study is to develop and pilot test a supportive care model, to enhance cancer care in this population.</p><p><strong>Methods: </strong>The model was developed through three phases. In phase I, a barrier analysis and prototype of the model were conducted from reviewing the literature and through 162 informal interviews with healthcare professionals, patients and patient representatives. In phase II, the prototype was refined through four workshops with a total of five cancer nurses, four clinical oncologists, three psychiatrists, two general practitioners, one psychologist, and 16 patient representatives. Thereafter, a pilot test with 13 patients was carried out, where continuous adaptations to the prototype from phase II, were made. The quantitative and qualitative data were analysed focusing on components which were prominent and able to fit into the clinical setting.</p><p><strong>Results: </strong>The final CASEMED supportive cancer care model included: Early identification of psychiatric comorbidity, engagement of significant caregivers, education of the oncological HCPs, securing continuity among staff and enhanced collaboration between sectors. The latter was achieved through an online psychiatric multidisciplinary team conference where the patient's general practitioner, a psychiatrist and the patient's oncologist participated.</p><p><strong>Conclusion: </strong>This study indicates that the model can be implemented in practice and has the potential to optimize cancer care for patients with cancer and pre-existing SMD. A larger feasibility study is currently being conducted.</p>","PeriodicalId":51048,"journal":{"name":"European Journal of Oncology Nursing","volume":"74 ","pages":"102748"},"PeriodicalIF":2.7,"publicationDate":"2024-11-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142796561","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluating the cost, cost-effectiveness and survival of an eHealth-facilitated integrated care model for allogeneic stem cell transplantation: Results of the German SMILe randomized, controlled implementation science trial 评估异体干细胞移植电子健康促进综合护理模式的成本、成本效益和存活率:德国 SMILe 随机对照实施科学试验的结果
IF 2.7 3区 医学 Q1 NURSING Pub Date : 2024-11-19 DOI: 10.1016/j.ejon.2024.102740
Lynn Leppla , Klaus Kaier , Anja Schmid , Sabine Valenta , Janette Ribaut , Juliane Mielke , Alexandra Teynor , Robert Zeiser , Sabina De Geest , SMILe study team
<div><h3>Purpose</h3><div>eHealth-facilitated integrated care models (eICMs) have proved effective in improving outcomes for chronically ill patients. However, evidence on cost-effectiveness of eICMs is scarce so far. Allogeneic stem cell transplantation (alloSCT) recipients' post-discharge treatment costs and mortality are greatly influenced by complications. Within the international, multicentric SMILe implementation science project, the eHealth-facilitated SMILe integrated care model (SMILe–<span>ICM</span>) was developed to support patients minimize complications' effects within the first year post-alloSCT.</div><div>Using initial effectiveness findings from the first center that implemented the SMILe-ICM, this study provides a cost and cost-effectiveness evaluation considering one-year and long-term survival effects, post-discharge costs, and patient-related factors.</div></div><div><h3>Methods</h3><div>A single-center hybrid effectiveness implementation randomized controlled trial was conducted at a German university hospital from 2/2020 to 8/2022. Eligible alloSCT patients were randomized to the SMILe–ICM or usual care, i.e., one pre-transplant educational nursing visit followed by a physician-led follow-up. The intervention group received usual care plus the SMILe-ICM's four intervention modules (i.e., monitoring of medical/symptom-related parameters, medication adherence, infection prevention, physical activity). All modules were delivered by Advanced Practice Nurses (APNs) in face-to-face visits, combined with continuous online support. Daily, patients entered seventeen medical and symptom-related parameters to the SMILe App, so that APNs could monitor for and investigate possible pre-complication signs. Healthcare utilization costs were assessed at eight time-points (d+30 post-alloSCT–d365) on fourteen self-reported cost indicators and validated against health records. To calculate costs, we applied German standardized unit costs. Cost- and cost-effectiveness were analyzed in five steps: 1.) Calculate total costs, including for the alloSCT inpatient stay and post-discharge follow-up. 2.) Determine life-years gained (survival) as a health benefit unit. 3.) Calculate overall and rehospitalization-free survival estimates. 4.) Calculate the intervention's long-term cost-effectiveness, including extended follow-up, rate of survival until day 1000, and restricted mean survival time. 5.) Contrast these long-term estimates to current post-discharge costs with comparable patient-related factors (age ≥ or < 65, living alone, gender).</div></div><div><h3>Results</h3><div>Seventy-two patients participated (n = 36/group). Total intergroup healthcare utilization and post-discharge costs differed, but non-significantly. Survival rates improved with the SMILe–ICM (88% vs. 80%) at least until day +1000. Rehospitalization-free survival showed improvement (38% vs. 30%); however, considering this sample size, both findings were nonsignificant. Cost-eff
目的 eHealth 推动的综合护理模式(eICMs)已被证明能有效改善慢性病患者的治疗效果。然而,迄今为止,有关eICM成本效益的证据还很少。异基因干细胞移植(alloSCT)受者出院后的治疗费用和死亡率在很大程度上受并发症的影响。在国际多中心SMILe实施科学项目中,开发了电子健康促进SMILe综合护理模式(SMILe-ICM),以支持患者在异体干细胞移植后第一年内最大限度地减少并发症的影响。本研究利用首个实施 SMILe-ICM 的中心的初步有效性研究结果,对一年和长期生存效果、出院后费用以及患者相关因素进行了成本和成本效益评估。方法 2020 年 2 月至 2022 年 8 月,在一家德国大学医院开展了一项单中心混合有效性实施随机对照试验。符合条件的alloSCT患者被随机分配到SMILe-ICM或常规护理中,即接受一次移植前教育护理访视,然后在医生指导下进行随访。干预组接受常规护理和 SMILe-ICM 的四个干预模块(即监测医疗/症状相关参数、坚持用药、预防感染、体育锻炼)。所有模块均由高级执业护士(APNs)通过面对面访问的方式提供,并结合持续的在线支持。患者每天在 SMILe 应用程序中输入十七项医疗和症状相关参数,以便高级护理师监测和调查可能出现的并发症前征兆。在八个时间点(骨髓造血干细胞移植术后 d+30 d-365),我们根据 14 项自我报告的成本指标评估了医疗保健使用成本,并根据健康记录进行了验证。在计算成本时,我们采用了德国标准化单位成本。成本和成本效益分析分为五个步骤:1.)计算总成本,包括 alloSCT 住院和出院后随访的成本。2.)确定作为健康效益单位的获益寿命(生存)。3.)计算总生存率和无再住院生存率。4.)计算干预措施的长期成本效益,包括延长随访时间、1000 天前的存活率和受限平均存活时间。5.)5.) 将这些长期估计值与当前出院后成本进行对比,同时考虑到与患者相关的可比因素(年龄≥或< 65岁、独居、性别)。组间医疗总利用率和出院后费用存在差异,但无显著性。使用SMILe-ICM后,至少在+1000天前的存活率有所提高(88%对80%)。无再住院生存率也有所提高(38% 对 30%);但考虑到样本量,这两项结果均不显著。成本效益分析表明,出院后的总体成本效益为 35,364.01 欧元/患者,6,742 欧元/生命年--在alloSCT 后的第一年,干预投资为 1.464 欧元/患者,平均增加 79.21 天的生命。独居患者的一年成本效益最高。结论 SMILe-ICM 似乎能为患者的生存和再住院带来益处,尤其是对弱势群体,如独居患者。要验证这些发现,还需要进行更大规模、有充分支持的研究。
{"title":"Evaluating the cost, cost-effectiveness and survival of an eHealth-facilitated integrated care model for allogeneic stem cell transplantation: Results of the German SMILe randomized, controlled implementation science trial","authors":"Lynn Leppla ,&nbsp;Klaus Kaier ,&nbsp;Anja Schmid ,&nbsp;Sabine Valenta ,&nbsp;Janette Ribaut ,&nbsp;Juliane Mielke ,&nbsp;Alexandra Teynor ,&nbsp;Robert Zeiser ,&nbsp;Sabina De Geest ,&nbsp;SMILe study team","doi":"10.1016/j.ejon.2024.102740","DOIUrl":"10.1016/j.ejon.2024.102740","url":null,"abstract":"&lt;div&gt;&lt;h3&gt;Purpose&lt;/h3&gt;&lt;div&gt;eHealth-facilitated integrated care models (eICMs) have proved effective in improving outcomes for chronically ill patients. However, evidence on cost-effectiveness of eICMs is scarce so far. Allogeneic stem cell transplantation (alloSCT) recipients' post-discharge treatment costs and mortality are greatly influenced by complications. Within the international, multicentric SMILe implementation science project, the eHealth-facilitated SMILe integrated care model (SMILe–&lt;span&gt;ICM&lt;/span&gt;) was developed to support patients minimize complications' effects within the first year post-alloSCT.&lt;/div&gt;&lt;div&gt;Using initial effectiveness findings from the first center that implemented the SMILe-ICM, this study provides a cost and cost-effectiveness evaluation considering one-year and long-term survival effects, post-discharge costs, and patient-related factors.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Methods&lt;/h3&gt;&lt;div&gt;A single-center hybrid effectiveness implementation randomized controlled trial was conducted at a German university hospital from 2/2020 to 8/2022. Eligible alloSCT patients were randomized to the SMILe–ICM or usual care, i.e., one pre-transplant educational nursing visit followed by a physician-led follow-up. The intervention group received usual care plus the SMILe-ICM's four intervention modules (i.e., monitoring of medical/symptom-related parameters, medication adherence, infection prevention, physical activity). All modules were delivered by Advanced Practice Nurses (APNs) in face-to-face visits, combined with continuous online support. Daily, patients entered seventeen medical and symptom-related parameters to the SMILe App, so that APNs could monitor for and investigate possible pre-complication signs. Healthcare utilization costs were assessed at eight time-points (d+30 post-alloSCT–d365) on fourteen self-reported cost indicators and validated against health records. To calculate costs, we applied German standardized unit costs. Cost- and cost-effectiveness were analyzed in five steps: 1.) Calculate total costs, including for the alloSCT inpatient stay and post-discharge follow-up. 2.) Determine life-years gained (survival) as a health benefit unit. 3.) Calculate overall and rehospitalization-free survival estimates. 4.) Calculate the intervention's long-term cost-effectiveness, including extended follow-up, rate of survival until day 1000, and restricted mean survival time. 5.) Contrast these long-term estimates to current post-discharge costs with comparable patient-related factors (age ≥ or &lt; 65, living alone, gender).&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Results&lt;/h3&gt;&lt;div&gt;Seventy-two patients participated (n = 36/group). Total intergroup healthcare utilization and post-discharge costs differed, but non-significantly. Survival rates improved with the SMILe–ICM (88% vs. 80%) at least until day +1000. Rehospitalization-free survival showed improvement (38% vs. 30%); however, considering this sample size, both findings were nonsignificant. Cost-eff","PeriodicalId":51048,"journal":{"name":"European Journal of Oncology Nursing","volume":"74 ","pages":"Article 102740"},"PeriodicalIF":2.7,"publicationDate":"2024-11-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142697411","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effects of a couple-based self-efficacy intervention on health outcomes among colorectal cancer patients and spousal caregivers: A randomized controlled trial. 基于夫妻自我效能感干预对结直肠癌患者及其配偶照顾者健康结局的影响:一项随机对照试验
IF 2.7 3区 医学 Q1 NURSING Pub Date : 2024-11-16 DOI: 10.1016/j.ejon.2024.102737
Jiali Gong, Meizhen Chen, Huamin Luo, Qiuping Li

Purpose: This study aimed to assess the feasibility and acceptability of a couple-based self-efficacy (SE) intervention, and to examine the effects of the intervention on health outcomes for CRC couples.

Methods: An assessor-blinded, two-armed, randomized controlled design was used. The study randomly assigned 144 patients hospitalized for colorectal cancer to receive either the SE intervention or the usual care. SE was the primary outcome. The secondary outcomes included quality of life and mental health (positive emotions and negative emotions). Repeated measures analysis of variance was used to examine the data.

Results: The recruitment and retention rates were 80% and 87.5%, respectively. First, we found that patients scored significantly higher on anxiety (p = 0.001), depression (p = 0.001) and benefit findings (p = 0.009) than did spousal caregivers, whereas spousal caregivers scored significantly higher than patients on the quality of life (p < 0.001 for both physical scores and mental scores) in the SE group. Second, immediately after the intervention, the SE group showed statistically significant improvements were found in SE (p < 0.001 for both couples), quality of life (mental scores) (p = 0.002 for spousal caregivers), negative emotion (anxiety, p < 0.05 for both couples; depression, p = 0.03 for patients), and positive emotion (benefit findings) (p < 0.001 for both couple) when compared to the control group.

Conclusion: A couple-based SE intervention significantly improved SE, quality of life (mental scores), and psychological well-being, suggesting a short-term intervention effect.

目的:本研究旨在评估基于夫妻自我效能感(SE)干预的可行性和可接受性,并探讨干预对结直肠癌夫妇健康结局的影响。方法:采用评估盲、双臂、随机对照设计。该研究随机分配了144名结直肠癌住院患者接受SE干预或常规护理。SE是主要结局。次要结果包括生活质量和心理健康(积极情绪和消极情绪)。采用重复测量方差分析对数据进行检验。结果:招聘率为80%,留用率为87.5%。首先,我们发现患者在焦虑(p = 0.001)、抑郁(p = 0.001)和福利结果(p = 0.009)方面的得分显著高于配偶照顾者,而配偶照顾者在生活质量方面的得分显著高于患者(p结论:基于配偶的SE干预显著改善了SE、生活质量(心理得分)和心理健康,表明干预效果是短期的。
{"title":"Effects of a couple-based self-efficacy intervention on health outcomes among colorectal cancer patients and spousal caregivers: A randomized controlled trial.","authors":"Jiali Gong, Meizhen Chen, Huamin Luo, Qiuping Li","doi":"10.1016/j.ejon.2024.102737","DOIUrl":"https://doi.org/10.1016/j.ejon.2024.102737","url":null,"abstract":"<p><strong>Purpose: </strong>This study aimed to assess the feasibility and acceptability of a couple-based self-efficacy (SE) intervention, and to examine the effects of the intervention on health outcomes for CRC couples.</p><p><strong>Methods: </strong>An assessor-blinded, two-armed, randomized controlled design was used. The study randomly assigned 144 patients hospitalized for colorectal cancer to receive either the SE intervention or the usual care. SE was the primary outcome. The secondary outcomes included quality of life and mental health (positive emotions and negative emotions). Repeated measures analysis of variance was used to examine the data.</p><p><strong>Results: </strong>The recruitment and retention rates were 80% and 87.5%, respectively. First, we found that patients scored significantly higher on anxiety (p = 0.001), depression (p = 0.001) and benefit findings (p = 0.009) than did spousal caregivers, whereas spousal caregivers scored significantly higher than patients on the quality of life (p < 0.001 for both physical scores and mental scores) in the SE group. Second, immediately after the intervention, the SE group showed statistically significant improvements were found in SE (p < 0.001 for both couples), quality of life (mental scores) (p = 0.002 for spousal caregivers), negative emotion (anxiety, p < 0.05 for both couples; depression, p = 0.03 for patients), and positive emotion (benefit findings) (p < 0.001 for both couple) when compared to the control group.</p><p><strong>Conclusion: </strong>A couple-based SE intervention significantly improved SE, quality of life (mental scores), and psychological well-being, suggesting a short-term intervention effect.</p>","PeriodicalId":51048,"journal":{"name":"European Journal of Oncology Nursing","volume":"74 ","pages":"102737"},"PeriodicalIF":2.7,"publicationDate":"2024-11-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142814768","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Fatigue, functional ability and quality of life in patients with bone and soft tissue sarcomas undergoing chemotherapy treatment: An observational study 接受化疗的骨和软组织肉瘤患者的疲劳、功能能力和生活质量:一项观察性研究。
IF 2.7 3区 医学 Q1 NURSING Pub Date : 2024-11-16 DOI: 10.1016/j.ejon.2024.102736
Mattia Morri, Riccardo Boccomino, Eugenio Brruku, Erika Romagnoli, Rita Boschi, Giovanni Raucci, Ausilia Bellina Terra, Paola Coluccino

Purpose

the aim of the study is to evaluate the presence of fatigue syndrome, the quality of life and functional ability of patients with bone and soft tissue sarcomas during the first 6 months of chemotherapy and identify possible prognostic factors.

Methods

prospective observational study was conducted. All patients about to start chemotherapy were consecutively recruited from July 2019 to April 2021. Patient fatigue, quality of life was measured at the start of chemotherapy and after 6 months. BFI score and EORTC QLQ C-30 was used respectively.

Results

The analysis of risk factors was performed on 98 patients. According to BFI score, in 36% of patients fatigue was classified from moderate to severe. The average global quality of life and TESS score increased by 3.9 and 8.5 points respectively. The strength of the association between the BFI score and EORTC subscales and TESS score was moderate (p < 0.001). Smoking status, higher BMI and impaired functional capabilities were independent predictive factors of fatigue.

Conclusion

Fatigue syndrome is present in a significant percentage of patients both at the start of chemotherapy treatment and in the following 6 months. Being a no smoker, higher BMI and impaired functional ability could impact fatigue syndrome. Fatigue screening, patient education and adapted aerobic exercise should be encouraged from the beginning of chemotherapy treatment. The quality of life and functional ability are associated with fatigue syndrome.

Registration number (clinicaltrial.gov)

NCT04104750 (26/09/2019)
目的:该研究旨在评估骨与软组织肉瘤患者在化疗前6个月是否存在疲劳综合征、生活质量和功能能力,并确定可能的预后因素。方法:该研究为前瞻性观察研究。从2019年7月至2021年4月连续招募所有即将开始化疗的患者。在化疗开始时和6个月后测量患者的疲劳度和生活质量。分别采用 BFI 评分和 EORTC QLQ C-30 结果:对 98 名患者进行了风险因素分析。根据 BFI 评分,36% 的患者疲劳程度为中度至重度。总体生活质量和 TESS 平均得分分别提高了 3.9 分和 8.5 分。BFI 评分与 EORTC 分量表和 TESS 评分之间的关联强度为中度(p 结论:疲劳综合征的发病率较低,但其死亡率较高:很大一部分患者在化疗开始时和随后的 6 个月中都会出现疲劳综合征。不吸烟、体重指数较高和功能受损可能会影响疲劳综合征。从化疗一开始,就应鼓励患者进行疲劳筛查、患者教育和有氧运动。生活质量和功能能力与疲劳综合征有关。注册号(clinicaltrial.gov):NCT04104750 (26/09/2019).
{"title":"Fatigue, functional ability and quality of life in patients with bone and soft tissue sarcomas undergoing chemotherapy treatment: An observational study","authors":"Mattia Morri,&nbsp;Riccardo Boccomino,&nbsp;Eugenio Brruku,&nbsp;Erika Romagnoli,&nbsp;Rita Boschi,&nbsp;Giovanni Raucci,&nbsp;Ausilia Bellina Terra,&nbsp;Paola Coluccino","doi":"10.1016/j.ejon.2024.102736","DOIUrl":"10.1016/j.ejon.2024.102736","url":null,"abstract":"<div><h3>Purpose</h3><div>the aim of the study is to evaluate the presence of fatigue syndrome, the quality of life and functional ability of patients with bone and soft tissue sarcomas during the first 6 months of chemotherapy and identify possible prognostic factors.</div></div><div><h3>Methods</h3><div>prospective observational study was conducted. All patients about to start chemotherapy were consecutively recruited from July 2019 to April 2021. Patient fatigue, quality of life was measured at the start of chemotherapy and after 6 months. BFI score and EORTC QLQ C-30 was used respectively.</div></div><div><h3>Results</h3><div>The analysis of risk factors was performed on 98 patients. According to BFI score, in 36% of patients fatigue was classified from moderate to severe. The average global quality of life and TESS score increased by 3.9 and 8.5 points respectively. The strength of the association between the BFI score and EORTC subscales and TESS score was moderate (p &lt; 0.001). Smoking status, higher BMI and impaired functional capabilities were independent predictive factors of fatigue.</div></div><div><h3>Conclusion</h3><div>Fatigue syndrome is present in a significant percentage of patients both at the start of chemotherapy treatment and in the following 6 months. Being a no smoker, higher BMI and impaired functional ability could impact fatigue syndrome. Fatigue screening, patient education and adapted aerobic exercise should be encouraged from the beginning of chemotherapy treatment. The quality of life and functional ability are associated with fatigue syndrome.</div></div><div><h3>Registration number (clinicaltrial.gov)</h3><div>NCT04104750 (26/09/2019)</div></div>","PeriodicalId":51048,"journal":{"name":"European Journal of Oncology Nursing","volume":"74 ","pages":"Article 102736"},"PeriodicalIF":2.7,"publicationDate":"2024-11-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142693880","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevalence and risk factors of chemotherapy-induced taste alterations among cancer patients: A systematic review and meta-analysis 化疗导致癌症患者味觉改变的发生率和风险因素:系统回顾与荟萃分析。
IF 2.7 3区 医学 Q1 NURSING Pub Date : 2024-11-16 DOI: 10.1016/j.ejon.2024.102735
Baoyi Zhang , Ni Zhang , Ye Zhang , Jingwen Yan , Lili Chen , Haiyan He , Shihao Sun , Yiheng Zhang , Meifen Zhang

Purpose

Chemotherapy-induced taste alterations (CiTA) are significant predictors of gastrointestinal symptoms, malnutrition, and poor prognosis. However, the prevalence and risk factors of CiTA vary substantially between studies. This study aimed to synthesize the prevalence and risk factors of CiTA among cancer patients.

Methods

Eight databases (Pubmed, Web of Science, Embase, ScienceDirect, Sinomed, China National Knowledge Infrastructure, Wanfang and Weipu database) were retrieved to collect observational studies regarding the prevalence or risk factors of CiTA published before June 1, 2024. The random effects meta-analysis was conducted to estimate the pooled prevalence. Subgroup analysis was conducted to identify heterogeneity across studies. For the same risk factor, the odds ratio and 95% confidence interval were calculated.

Results

In total, 30 studies with 15,722 participants were included. The pooled prevalence of CiTA was 70.0% (95% CI: 59.1%–79.9%, I2 = 99.4%), ranging from 21.0% to 100.0%. Female (OR = 2.59, 95% CI: 1.59 to 4.22), patients with xerostomia (OR = 2.04, 95% CI: 1.48 to 2.81), oral mucositis/ulcers (OR = 3.72, 95% CI: 1.46 to 9.47), receiving not less than 2 chemotherapy cycles (OR = 3.95, 95% CI: 3.20 to 4.88) were more likely to develop CiTA.

Conclusions

The prevalence of CiTA among cancer patients was alarmingly high. Female, xerostomia, oral mucositis/ulcers, receiving not less than 2 chemotherapy cycles were significant risk factors of CiTA. Healthcare practitioners should identify high-risk patients and develop targeted interventions to manage CiTA based on identified risk factors.
目的:化疗引起的味觉改变(CiTA)是预测胃肠道症状、营养不良和预后不良的重要因素。然而,不同研究对 CiTA 的发生率和风险因素的研究差异很大。本研究旨在综合癌症患者中 CiTA 的患病率和风险因素:检索8个数据库(Pubmed、Web of Science、Embase、ScienceDirect、Sinomed、中国国家知识基础设施、万方和卫普数据库),收集2024年6月1日前发表的有关CiTA患病率或危险因素的观察性研究。采用随机效应荟萃分析法估算汇总患病率。为确定不同研究间的异质性,还进行了分组分析。对于同一风险因素,计算了几率比和 95% 的置信区间:共纳入了 30 项研究,15722 名参与者。汇总的 CiTA 患病率为 70.0%(95% CI:59.1%-79.9%,I2 = 99.4%),范围从 21.0% 到 100.0%。女性(OR = 2.59,95% CI:1.59 至 4.22)、有口腔干燥症(OR = 2.04,95% CI:1.48 至 2.81)、口腔粘膜炎/溃疡(OR = 3.72,95% CI:1.46 至 9.47)、接受不少于 2 个化疗周期(OR = 3.95,95% CI:3.20 至 4.88)的患者更有可能患上 CiTA:结论:CiTA在癌症患者中的发病率之高令人震惊。女性、口腔干燥症、口腔粘膜炎/溃疡、接受不少于 2 个化疗周期是 CiTA 的重要风险因素。医护人员应识别高危患者,并根据识别出的风险因素制定有针对性的干预措施来控制 CiTA。
{"title":"Prevalence and risk factors of chemotherapy-induced taste alterations among cancer patients: A systematic review and meta-analysis","authors":"Baoyi Zhang ,&nbsp;Ni Zhang ,&nbsp;Ye Zhang ,&nbsp;Jingwen Yan ,&nbsp;Lili Chen ,&nbsp;Haiyan He ,&nbsp;Shihao Sun ,&nbsp;Yiheng Zhang ,&nbsp;Meifen Zhang","doi":"10.1016/j.ejon.2024.102735","DOIUrl":"10.1016/j.ejon.2024.102735","url":null,"abstract":"<div><h3>Purpose</h3><div>Chemotherapy-induced taste alterations (CiTA) are significant predictors of gastrointestinal symptoms, malnutrition, and poor prognosis. However, the prevalence and risk factors of CiTA vary substantially between studies. This study aimed to synthesize the prevalence and risk factors of CiTA among cancer patients.</div></div><div><h3>Methods</h3><div>Eight databases (Pubmed, Web of Science, Embase, ScienceDirect, Sinomed, China National Knowledge Infrastructure, Wanfang and Weipu database) were retrieved to collect observational studies regarding the prevalence or risk factors of CiTA published before June 1, 2024. The random effects meta-analysis was conducted to estimate the pooled prevalence. Subgroup analysis was conducted to identify heterogeneity across studies. For the same risk factor, the odds ratio and 95% confidence interval were calculated.</div></div><div><h3>Results</h3><div>In total, 30 studies with 15,722 participants were included. The pooled prevalence of CiTA was 70.0% (95% <em>CI</em>: 59.1%–79.9%, <em>I</em><sup><em>2</em></sup> = 99.4%), ranging from 21.0% to 100.0%. Female (<em>OR</em> = 2.59, 95% <em>CI</em>: 1.59 to 4.22), patients with xerostomia (<em>OR</em> = 2.04, 95% <em>CI</em>: 1.48 to 2.81), oral mucositis/ulcers (<em>OR</em> = 3.72, 95% <em>CI</em>: 1.46 to 9.47), receiving not less than 2 chemotherapy cycles (<em>OR</em> = 3.95, 95% <em>CI</em>: 3.20 to 4.88) were more likely to develop CiTA.</div></div><div><h3>Conclusions</h3><div>The prevalence of CiTA among cancer patients was alarmingly high. Female, xerostomia, oral mucositis/ulcers, receiving not less than 2 chemotherapy cycles were significant risk factors of CiTA. Healthcare practitioners should identify high-risk patients and develop targeted interventions to manage CiTA based on identified risk factors.</div></div>","PeriodicalId":51048,"journal":{"name":"European Journal of Oncology Nursing","volume":"74 ","pages":"Article 102735"},"PeriodicalIF":2.7,"publicationDate":"2024-11-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142695316","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The longitudinal association between resilience and sleep quality in breast cancer 乳腺癌患者的恢复力与睡眠质量之间的纵向联系。
IF 2.7 3区 医学 Q1 NURSING Pub Date : 2024-11-15 DOI: 10.1016/j.ejon.2024.102734
Shuhan Li , Qingxin Mai , Xiaoxiao Mei , Yingting Jiang , Ying Xiong , Yihao Zeng , M.Tish Knobf , Zengjie Ye

Purpose

To estimate the longitudinal association between resilience and sleep quality in patients with newly diagnosed breast cancer within the first 6 months.

Method

Between July 2023 and September 2023, 155 newly diagnosed BC patients were recruited to participate in the Be Resilience to Breast Cancer program (Abbreviated as BRBC). They completed the 10-item Connor-Davidson Resilience scale and Pittsburgh Sleep Quality Index Scale. The following three timepoints were set to collect the data, including 1 month after initial diagnosis (T0), 3 months (T1), and 6 months (T2). Data were analyzed using Cross-lagged Panel Model (CLPM), and Parallel Latent Growth Model (PLGM).

Results

Excluded questionnaires with a large number of missing items and finally 125 patients were included, with the response rate of 83.3%. CLPM indicated that resilience at T1 predicted PSQI at T2 (r = −0.168, P < 0.001), and PSQI at T1 predicted resilience at T2 (r = −0.112, P< 0.001). PLGM demonstrated that changes in resilience was significantly associated with changes in PSQI (r = −0.874, P< 0.001).

Conclusion

A longitudinal association between resilience and sleep quality was confirmed in patients with newly diagnosed breast cancer. Resilience was a protective factor in the development of sleep quality.
目的:估算新确诊乳腺癌患者在最初6个月内的恢复力与睡眠质量之间的纵向关系:在 2023 年 7 月至 2023 年 9 月期间,招募了 155 名新确诊的乳腺癌患者参加 "乳腺癌抗逆力 "项目(简称 BRBC)。他们完成了 10 项康纳-戴维森复原力量表和匹兹堡睡眠质量指数量表。数据收集设置了三个时间点,包括初次诊断后 1 个月(T0)、3 个月(T1)和 6 个月(T2)。数据分析采用交叉滞后面板模型(CLPM)和平行潜增长模型(PLGM):排除了大量缺失项目的问卷,最终纳入了 125 名患者,回复率为 83.3%。CLPM表明,T1时的恢复力预测T2时的PSQI(r = -0.168,P < 0.001),T1时的PSQI预测T2时的恢复力(r = -0.112,P < 0.001)。PLGM表明,恢复力的变化与PSQI的变化有显著相关性(r = -0.874,P< 0.001):结论:在新诊断的乳腺癌患者中,复原力与睡眠质量之间的纵向联系得到了证实。复原力是睡眠质量发展的保护因素。
{"title":"The longitudinal association between resilience and sleep quality in breast cancer","authors":"Shuhan Li ,&nbsp;Qingxin Mai ,&nbsp;Xiaoxiao Mei ,&nbsp;Yingting Jiang ,&nbsp;Ying Xiong ,&nbsp;Yihao Zeng ,&nbsp;M.Tish Knobf ,&nbsp;Zengjie Ye","doi":"10.1016/j.ejon.2024.102734","DOIUrl":"10.1016/j.ejon.2024.102734","url":null,"abstract":"<div><h3>Purpose</h3><div>To estimate the longitudinal association between resilience and sleep quality in patients with newly diagnosed breast cancer within the first 6 months.</div></div><div><h3>Method</h3><div>Between July 2023 and September 2023, 155 newly diagnosed BC patients were recruited to participate in the Be Resilience to Breast Cancer program (Abbreviated as BRBC). They completed the 10-item Connor-Davidson Resilience scale and Pittsburgh Sleep Quality Index Scale. The following three timepoints were set to collect the data, including 1 month after initial diagnosis (T0), 3 months (T1), and 6 months (T2). Data were analyzed using Cross-lagged Panel Model (CLPM), and Parallel Latent Growth Model (PLGM).</div></div><div><h3>Results</h3><div>Excluded questionnaires with a large number of missing items and finally 125 patients were included, with the response rate of 83.3%. CLPM indicated that resilience at T1 predicted PSQI at T2 (r = −0.168, P <span><math><mrow><mo>&lt;</mo></mrow></math></span> 0.001), and PSQI at T1 predicted resilience at T2 (r = −0.112, P<span><math><mrow><mo>&lt;</mo></mrow></math></span> 0.001). PLGM demonstrated that changes in resilience was significantly associated with changes in PSQI (r = −0.874, P<span><math><mrow><mo>&lt;</mo></mrow></math></span> 0.001).</div></div><div><h3>Conclusion</h3><div>A longitudinal association between resilience and sleep quality was confirmed in patients with newly diagnosed breast cancer. Resilience was a protective factor in the development of sleep quality.</div></div>","PeriodicalId":51048,"journal":{"name":"European Journal of Oncology Nursing","volume":"74 ","pages":"Article 102734"},"PeriodicalIF":2.7,"publicationDate":"2024-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142689400","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
European Journal of Oncology Nursing
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1